Results 141 to 150 of about 73,881 (259)

Gi4SaveLife: a community-led model for sustainable voluntary blood donation in rural Sierra Leone. [PDF]

BMJ Glob Health
Fernandez Turienzo C, November L, Turay M, Kamara P, Lassie RK, Kamara JS, Kamara MK, Kamara M, Duraman M, Kuhrt K, Leather AJM, Gevao S, Williams PT.   +12 more
europepmc   +1 more source

CHLOROQUINE FOR DONATED BLOOD?

The Lancet, 1987
openaire   +2 more sources

IGF2 knockout reduces but does not abolish osteosarcoma growth in vitro and in vivo

FEBS Open Bio, EarlyView.
To test whether endogenous IGF2 promotes osteosarcoma growth, IGF2 was knocked out in Saos2 cells via CRISPR‐Cas9. KO cells showed reduced proliferation in vitro, and knockout xenografts in mice reached only ~25% of wild‐type tumor volume. Insulin‐like growth factor 2 (IGF2) is implicated in osteosarcoma, but direct functional evidence of its role is ...
Shun Yao, Marco Archetti
wiley   +1 more source

The efficacy of interactive communication interventions for motivating blood donation: A systematic review. [PDF]

Vox Sang
Boult L, Douglass T, Tremblett M, Joyce JB.   +3 more
europepmc   +1 more source

Chronobiology of Cancer: How Aging Fuels Oncogenesis at the Molecular Level

Aging and Cancer, EarlyView.
This graphical abstract illustrates the key biological pathways linking aging with cancer development and progression. In the upper left, cumulative exposure to ultraviolet radiation, toxins, and reactive oxygen species (ROS) causes DNA damage and genomic instability, whereas age‐related decline in repair mechanisms, such as ATM/ATR, BER, and NER ...
Anu Singh, Aroonima Misra, Sufian Zaheer
wiley   +1 more source

Knowledge, Attitudes, Motivations, and Practices of Blood Donation Among the Population of Saudi Arabia. [PDF]

Healthcare (Basel)
Altilasi SI, Hamze D, Elsarrag M, Sajid MR, Aldosari S.   +4 more
europepmc   +1 more source

Understanding and Mitigating the Risk of Accelerated Biological Aging in Survivors of Cancer: A Scoping Review

Aging and Cancer, EarlyView.
Cancer treatment is associated with measurable acceleration of biological aging across epigenetic, telomere, senescence, and immune biomarkers. However, biomarker validation and interventional strategies remain limited, especially in hematologic malignancies, underscoring the need for standardized multi‐omic aging assessments and adequately powered ...
Moataz Ellithi, Emily Herdman, Danielle Westmark, Vijaya R. Bhatt   +3 more
wiley   +1 more source

Core influencing factors of group blood donation in Beijing. [PDF]

Front Public Health
Liu R.
europepmc   +1 more source

Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants

Annals of Clinical and Translational Neurology, EarlyView.
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold, Krzysztof W. Selmaj, Regina Berkovich, Jeffrey A. Cohen, Giancarlo Comi, Eva K. Havrdová, James K. Sheffield, Hetal Desai, Chun‐Yen Cheng, Jon V. Riolo, Andrew Thorpe, Erik DeBoer, Bruce A. C. Cree   +12 more
wiley   +1 more source

What is the impact of whole-blood donation frequency on donor health? A systematic review. [PDF]

Vox Sang
Severijns P, D'aes T, De Buck E, Van Remoortel H.   +3 more
europepmc   +1 more source